FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321292976> ?p ?o ?g. }

• W2321292976 endingPage "184S" @default.
• W2321292976 startingPage "183S" @default.
• W2321292976 abstract "INTRODUCTION: To describe the short-term perioperative outcomes and overall survival among women with venous thromboembolism (VTE) at initial epithelial ovarian cancer diagnosis. METHODS: Women presenting with VTE within 30 days of epithelial ovarian cancer diagnosis between January 2, 2003, and December 29, 2011, who had primary debulking surgery or primarily managed with neoadjuvant chemotherapy were included. Descriptive statistics and the Kaplan-Meier method were used to estimate overall survival from the time of epithelial ovarian cancer diagnosis with patient characteristics and process-of-care variables retrospectively abstracted. RESULTS: Of the 37 women with VTE within 30 days before epithelial ovarian cancer diagnosis, 28 (75.7%; mean age 64.2 years) underwent primary debulking surgery and 9 (24.3%; mean age 62.7 years) received neoadjuvant chemotherapy. Eastern Cooperative Oncology Group performance status was 0–1 in 75% (n=21) of patients undergoing primary debulking surgery compared with 44% (n=4) of patients undergoing neoadjuvant chemotherapy. Advanced-stage (III–IV) disease was diagnosed in 71.4% (n=20) of the primary debulking surgery cohort; all patients undergoing neoadjuvant chemotherapy were presumed advanced. Among those who underwent primary debulking surgery, 26 (92.9%) had a preoperative inferior vena cava filter placed; only one (11.1%) in the neoadjuvant chemotherapy cohort received an inferior vena cava filter. Perioperative bleeding complications were rare in the primary debulking surgery cohort. Within the primary debulking surgery cohort, median overall survival was 2.14 years and median overall survival in the neoadjuvant chemotherapy cohort was 8.8 months (Fig. 1).CONCLUSIONS: Despite preoperative VTE, median overall survival was improved among patients undergoing primary debulking surgery; however, poorer overall survival in the neoadjuvant chemotherapy cohort may reflect a worse performance status or higher proportion of advanced cancer. Preoperative VTE in patients with epithelial ovarian cancer can be safely managed with low rates of bleeding complications." @default.
• W2321292976 created "2016-06-24" @default.
• W2321292976 creator A5003622584 @default.
• W2321292976 creator A5010282758 @default.
• W2321292976 creator A5031945893 @default.
• W2321292976 creator A5037747913 @default.
• W2321292976 creator A5067520596 @default.
• W2321292976 creator A5090082059 @default.
• W2321292976 date "2014-05-01" @default.
• W2321292976 modified "2023-09-22" @default.
• W2321292976 title "Management of Epithelial Ovarian Cancer in the Setting of Concomitant Venous Thromboembolism" @default.
• W2321292976 doi "https://doi.org/10.1097/01.aog.0000447204.35797.4a" @default.
• W2321292976 hasPublicationYear "2014" @default.
• W2321292976 type Work @default.
• W2321292976 sameAs 2321292976 @default.
• W2321292976 citedByCount "0" @default.
• W2321292976 crossrefType "journal-article" @default.
• W2321292976 hasAuthorship W2321292976A5003622584 @default.
• W2321292976 hasAuthorship W2321292976A5010282758 @default.
• W2321292976 hasAuthorship W2321292976A5031945893 @default.
• W2321292976 hasAuthorship W2321292976A5037747913 @default.
• W2321292976 hasAuthorship W2321292976A5067520596 @default.
• W2321292976 hasAuthorship W2321292976A5090082059 @default.
• W2321292976 hasConcept C121608353 @default.
• W2321292976 hasConcept C126322002 @default.
• W2321292976 hasConcept C141071460 @default.
• W2321292976 hasConcept C2776694085 @default.
• W2321292976 hasConcept C2780427987 @default.
• W2321292976 hasConcept C2781100745 @default.
• W2321292976 hasConcept C31174226 @default.
• W2321292976 hasConcept C71924100 @default.
• W2321292976 hasConcept C72563966 @default.
• W2321292976 hasConceptScore W2321292976C121608353 @default.
• W2321292976 hasConceptScore W2321292976C126322002 @default.
• W2321292976 hasConceptScore W2321292976C141071460 @default.
• W2321292976 hasConceptScore W2321292976C2776694085 @default.
• W2321292976 hasConceptScore W2321292976C2780427987 @default.
• W2321292976 hasConceptScore W2321292976C2781100745 @default.
• W2321292976 hasConceptScore W2321292976C31174226 @default.
• W2321292976 hasConceptScore W2321292976C71924100 @default.
• W2321292976 hasConceptScore W2321292976C72563966 @default.
• W2321292976 hasIssue "Supplement 1" @default.
• W2321292976 hasLocation W23212929761 @default.
• W2321292976 hasOpenAccess W2321292976 @default.
• W2321292976 hasPrimaryLocation W23212929761 @default.
• W2321292976 hasRelatedWork W2065800215 @default.
• W2321292976 hasRelatedWork W2133480631 @default.
• W2321292976 hasRelatedWork W2171986270 @default.
• W2321292976 hasRelatedWork W2178706672 @default.
• W2321292976 hasRelatedWork W2377725145 @default.
• W2321292976 hasRelatedWork W2944256364 @default.
• W2321292976 hasRelatedWork W3097676887 @default.
• W2321292976 hasRelatedWork W4292318906 @default.
• W2321292976 hasRelatedWork W59268075 @default.
• W2321292976 hasRelatedWork W74951144 @default.
• W2321292976 hasVolume "123" @default.
• W2321292976 isParatext "false" @default.
• W2321292976 isRetracted "false" @default.
• W2321292976 magId "2321292976" @default.
• W2321292976 workType "article" @default.